852180-47-3

Basic information

• Product Name: TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE
• Synonyms: N1-BOC-4-(AMINOMETHYL)PHENYLPIPERAZINE;tert-Butyl 4-[4-(aminomethyl)phenyl]piperazine-1-carboxylate, 4-[4-(tert-Butoxycarbonyl)piperazin-1-yl]benzylamine;tert-Butyl 4-(4-(aMinoMethyl)phenyl)piperazine-1-carboxylate;4-(4-Aminomethylphenyl)piperazine-1-carboxylic acid tert-butyl ester;4-[(Aminomethyl)phenyl]piperazine,N1-BOCprotected90%;4-(AMINOMETHYL)PHENYLPIPERAZINE, N1-BOC PROTECTED;1-BOC-4-(4-AMINOMETHYL-PHENYL)-PIPERAZINE;1-(4-AMINOMETHYL-PHENYL)-PIPERAZINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER
• CAS NO: 852180-47-3
• Molecular Formula: C₁₆H₂₅N₃O₂
• Molecular Weight: 291.39
• Mol File: 852180-47-3.mol

Chemical Properties

• Melting Point: 95-96°C
• Boiling Point: 441°C at 760 mmHg
• Flash Point: 220.5°C
• Appearance: /
• Density: 1.121g/cm³
• Vapor Pressure: 5.62E-08mmHg at 25°C
• Refractive Index: 1.553
• PKA: 10.40±0.10(Predicted)
• CAS DataBase Reference: TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(852180-47-3)
• EPA Substance Registry System: TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(852180-47-3)

Safety Data

• Hazard Codes: T
• Statements: 36/37/38-25
• Safety Statements: 26-36/37/39-45
• HazardClass: IRRITANT
• Hazardous Substances Data: 852180-47-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is used as a building block in organic synthesis for the creation of various pharmaceutical drugs and biologically active molecules, leveraging its complex structure and unique functional groups.
Used in Pharmaceutical Research:
In the pharmaceutical industry, TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is used as a precursor for the synthesis of pharmaceutical compounds, potentially serving as a drug candidate due to its distinctive pharmacophore. Further research is necessary to explore its full potential and effects in this field.
While the provided materials do not specify particular applications or industries beyond organic synthesis and pharmaceutical research, the compound's potential uses are likely to be explored in various sectors where novel chemical entities are of interest, such as agrochemicals, materials science, and other areas of chemical research and development.

InChI:InChI=1/C16H25N3O2/c1-16(2,3)21-15(20)19-10-8-18(9-11-19)14-6-4-13(12-17)5-7-14/h4-7H,8-12,17H2,1-3H3

Upstream product

• 1194-02-1 4-fluorobenzonitrile 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 623-00-7 4-bromobenzenecarbonitrile 
• 186650-98-6 tert-butyl 4-(4-cyanophenyl)piperazine-1-carboxylate 

Downstream Products

• 831203-79-3 4-(4-{[(5-nitro-furan-2-carbonyl)-amino]-methyl}-phenyl)-piperzine-1-carboxylic acid ter-butyl ester 
• 831203-80-6 5-nitro-furan-2-carboxylic acid 4-piperazin-1-yl-benzylamide 
• 1038388-18-9 C₃₁H₃₅N₅O₅S 
• 1149380-80-2 1,1-dimethylethyl 4-(4-{[({6-[3-endo-({[2-methyl-3-(methyloxy)phenyl]carbonyl}amino)-8-azabicyclo[3.2.1]oct-8-yl]pyridine-3-yl}carbonyl)amino]methyl}phenyl)piperazine-1-carboxylate 
• 1033693-69-4 tert-butyl 4-{4-[(3-isobutyl-2,5-dioxo-2,3-dihydroimidazo[2,1-b]quinazolin-1(5H)-yl)methyl]phenyl}piperazine-1-carboxylate 
• 1349745-15-8 tert-butyl 4-(4-((2-chloro-5-methoxy-4-nitrophenethylamino)methyl)phenyl)piperazine-1-carboxylate 
• 1403940-97-5 6-chloro-2-ethyl-N-(4-(4-(4-fluorobenzoyl)piperazin-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide 

Relevant articles and documents

Benzoquinone derivative, pharmaceutical composition, and applications thereof

The invention discloses a benzoquinone derivative, a pharmaceutical composition, and applications thereof. According to the invention, the benzoquinone derivative (I), and the stereoisomer or the pharmaceutically acceptable salt thereof possess a structure disclosed in the invention. The benzoquinone derivative possesses excellent inhibition effect on STAT3 level both in vivo and in vitro, and further, the benzoquinone derivative is capable of inhibiting balling capacity of cancer cells.

Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203

The anti-tubercular activity of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidin-1-yl)benzyl)imidazo [1,2-a]pyridine-3-carboxamide (Q203) is modified by varying its side chain. In this study, we synthesized Q203 analogues with different side

ANTI-INFECTIVE COMPOUNDS

The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.

Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improved bioavailability

Previously, the lead compound 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide was identified in our anti-tuberculosis drug discovery program. Although this compound demonstrated excellent in vitro activity, it did not meet the expe